Novartis hopeful for novel heart drug, despite `modest` benefit

Published 9y ago

Novartis will seek regulatory approval this year for a new kind of anti-inflammatory heart drug, though some experts fear fatal infection risks and a high price may overshadow the medicine's limited benefits. More »